WTO Quantitative Restrictions

Singapore #9107 (v.2)

Base data

Notified in
Version validity
01/09/2024 - present
Current active version v.2
Reporting member
Singapore
In force from
End date
In force
General description
Non-automatic licence for the import of Chinese proprietary medicines (CPMs)
National legal basis
Medicines Act, 1975

Date of Entry into force: 30 March 1987

The latest version of the measure became effective on 1 November 2022
Administrative mechanism
While the controls of chemical and biologic drugs have been transferred from the Medicines Act to the Health Products Act from 1 Nov 2016, CPMs will continue to be regulated under the Medicines Act for now.

More information can be found at: https://www.hsa.gov.sg/.

Administered by HSA.
Responsible entities
HS version
HS 2022
Referenced WTO document symbol

Meta data

WTO justifications

XX:(b) - (b) necessary to protect human, animal or plant life or health;

GATT 1994 (GATT 1947 provisions)

Reported as: Article XX(b) of the GATT
Non-WTO commitments
Affected partners
Non-affected partners

Measures

Reported restrictions
NAL
Symbol
NAL

Tariff lines
12
Chapter 12
Chinese proprietary medicines (CPMs) refer to medicinal products, used according to the traditional...
13
Chapter 13
Chinese proprietary medicines (CPMs) refer to medicinal products, used according to the traditional...
30
Chapter 30
Chinese proprietary medicines (CPMs) refer to medicinal products, used according to the traditional...